Summary:
This research study is to determine which of the advanced-stage cancer types being evaluated (breast, lung, prostate, and/or ovarian cancer) shed rare cells in the blood that can be captured by a disposable cassette called the Parsortix system.
Criteria:- Be 18 years or older at the time of consent
- Must be diagnosed with advanced stage III or IV: breast, ovarian, lung, or prostate cancer
- Willing to complete 1 blood draw a month for 6 months
- Willing to sign an informed consent
Qualified Participants May Receive:
- $100 per completed study visit up to 6 visits
- Transportation at no cost to you